SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Update on share buyback programmes

13 Oct 2023 07:00

RNS Number : 9954P
Bridgepoint Group plc
13 October 2023

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER FOR SALE OF ANY SECURITIES OR AN OFFER OR INVITATION TO PURCHASE ANY SECURITIES IN ANY JURISDICTION OR A SOLICITATION OF ANY VOTE OR APPROVAL.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (DIRECTLY OR INDIRECTLY) IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

Bridgepoint Group plc ("Bridgepoint")

Completion of share buyback programme and commencement of New Buyback Programme

Further to Bridgepoint's announcement on 2 October 2023, Bridgepoint announces that yesterday it commenced the share buyback programme of up to £50 million detailed in the announcement of 2 October 2023 (the "New Buyback Programme"), following completion on 11 October 2023 of the share buyback programme of up to £50 million announced on 24 January 2023. The New Buyback Programme is envisaged to complete before 31 July 2024.

ENQUIRIES

Bridgepoint

Analysts and investors

Adam Key

adam.key@bridgepoint.eu

+44 7833 748010

Media

Christian Jones / James Murray

christian.jones@bridgepoint.eu james.murray@bridgepoint.eu

+44 20 7034 3500

FGS Global (Public Relations Adviser to Bridgepoint)

Charles O'Brien / +44 20 7251 3801 / +44 7825 043 656

Anjali Unnikrishnan / +44 20 7251 3801 / +44 7826 534 233

bridgepoint@fgsglobal.com

Legal Entity Identifier (LEI): 213800KFNMVI8PDZX472

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSUUUWROOURAAA

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS